Your browser doesn't support javascript.
loading
Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer disease.
Buckles, Virginia D; Xiong, Chengjie; Bateman, Randall J; Hassenstab, Jason; Allegri, Ricardo; Berman, Sarah B; Chhatwal, Jasmeer P; Danek, Adrian; Fagan, Anne M; Ghetti, Bernardino; Goate, Alison; Graff-Radford, Neill; Jucker, Mathias; Levin, Johannes; Marcus, Daniel S; Masters, Colin L; McCue, Lena; McDade, Eric; Mori, Hiroshi; Moulder, Krista L; Noble, James M; Paumier, Katrina; Preische, Oliver; Ringman, John M; Fox, Nick C; Salloway, Stephen; Schofield, Peter R; Martins, Ralph; Vöglein, Jonathan; Morris, John C.
Afiliación
  • Buckles VD; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Xiong C; Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Bateman RJ; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Hassenstab J; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Allegri R; Institute for Neurological Research (FLENI), Buenos Aires, Argentina.
  • Berman SB; Department of Neurology and Clinical and Translational Science, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Chhatwal JP; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Danek A; Neurologische Klinik und Poliklinik, Klinikum der Universität München, Munich, Germany.
  • Fagan AM; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Ghetti B; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Goate A; Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Graff-Radford N; Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA.
  • Jucker M; DZNE Tuebingen & Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.
  • Levin J; DZNE Munich, Munich Cluster of Systems Neurology (SyNergy) & Ludwig-Maximilians-Universität, Munich, Germany.
  • Marcus DS; Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Masters CL; Florey Institute, University of Melbourne, Melbourne, Australia.
  • McCue L; Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri, USA.
  • McDade E; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Mori H; Department of Neuroscience, Osaka City University Medical School, Osaka City, Japan.
  • Moulder KL; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Noble JM; Department of Neurology, Taub Institute for Research on Aging Brain, Columbia University Irving Medical Center, New York, New York, USA.
  • Paumier K; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Preische O; DZNE Tuebingen & University of Tuebingen, Tuebingen, Germany.
  • Ringman JM; Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Fox NC; Department of Neurodegenerative Disease & UK Dementia Research Institute, Institute of Neurology, London, UK.
  • Salloway S; Department of Neurology, Butler Hospital & Alpert Medical School of Brown University, Providence, Rhode Island, USA.
  • Schofield PR; Neuroscience Research Australia & School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia.
  • Martins R; Sir James McCusker Alzheimer's Disease Research Unit, Edith Cowan University, Nedlands, Western Australia, Australia.
  • Vöglein J; German Center for Neurodegenerative Diseases (DZNE) and Department of Neurology, Ludwig-Maximilians Universität München, Munich, Germany.
  • Morris JC; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
Alzheimers Dement ; 18(10): 1754-1764, 2022 10.
Article en En | MEDLINE | ID: mdl-34854530
As prevention trials advance with autosomal dominant Alzheimer disease (ADAD) participants, understanding the similarities and differences between ADAD and "sporadic" late-onset AD (LOAD) is critical to determine generalizability of findings between these cohorts. Cognitive trajectories of ADAD mutation carriers (MCs) and autopsy-confirmed LOAD individuals were compared to address this question. Longitudinal rates of change on cognitive measures were compared in ADAD MCs (n = 310) and autopsy-confirmed LOAD participants (n = 163) before and after symptom onset (estimated/observed). LOAD participants declined more rapidly in the presymptomatic (preclinical) period and performed more poorly at symptom onset than ADAD participants on a cognitive composite. After symptom onset, however, the younger ADAD MCs declined more rapidly. The similar but not identical cognitive trajectories (declining but at different rates) for ADAD and LOAD suggest common AD pathologies but with some differences.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_doencas_nao_transmissiveis Asunto principal: Enfermedad de Alzheimer / Disfunción Cognitiva Límite: Humans Idioma: En Revista: Alzheimers Dement Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_doencas_nao_transmissiveis Asunto principal: Enfermedad de Alzheimer / Disfunción Cognitiva Límite: Humans Idioma: En Revista: Alzheimers Dement Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
...